Shuffling for industrial innovation

OXFORD - Novo Nordisk A/S, one of the world's most established bioscience companies, is linking up with Maxygen Inc., one of the youngest companies, to develop the next generation of industrial enzymes and proteins. The companies have entered a licensing agreement and five-year R&D collaborative program

Read the full 460 word article

How to gain access

Continue reading with a
two-week free trial.